In summary, we designed a novel model of “de novo” KSHV oncogenesis based on infection of PDGFRA-positive mesenchymal stem cell progenitors cultured in pro-angiogenic/vasculogenic KS-like growth conditions. The gene discussed is PDGFRA; the disease is Kaposi's sarcoma.